307750 — Kukjeon Pharmaceutical Co Income Statement
0.000.00%
Last trade - 00:00- KR₩175bn
- KR₩196bn
- KR₩136bn
Annual income statement for Kukjeon Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 80,623 | 85,354 | 103,711 | 121,998 | 136,468 |
| Cost of Revenue | |||||
| Gross Profit | 14,518 | 17,946 | 19,515 | 25,277 | 21,874 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 74,830 | 79,219 | 100,201 | 115,497 | 138,790 |
| Operating Profit | 5,793 | 6,135 | 3,510 | 6,501 | -2,322 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2,315 | 5,084 | 11,088 | 1,738 | 879 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3,317 | 4,038 | 8,877 | 4,692 | 538 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -3,317 | 4,038 | 8,948 | 4,824 | 1,736 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -3,317 | 4,038 | 8,948 | 4,824 | 1,736 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -92.6 | 91.5 | 183 | 98.3 | 69.6 |
| Dividends per Share |